Stocks · Healthcare · Medical - Healthcare Information Services
NRC Health NRC
$20.35 -4.55% Close, Oct 2, 2026 · NASDAQ · Market cap $458.6M
High quality
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.25, down 67.0% year over year.
- At 80.6× trailing earnings, the shares trade at the highest P/E of the company's past five years.
- Operating margin narrowed to 10.5% from 19.8% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 29%
- EPS growth (TTM, YoY)Bottom 23%
- FCF growth (TTM, YoY)Top 13%
- Revenue growth, 3-year CAGRBottom 18%
- Revenue growth accelerationTop 31%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 17%
- Gross marginTop 47%
- Operating marginTop 26%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 18%
- Net debt / EBITDA (lower is better)Bottom 21%
- Interest coverTop 34%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 26%
- Free-cash-flow yieldTop 19%
- EBITDA / enterprise valueTop 26%
- Sales / enterprise valueTop 47%
- P/E vs own 5-year history (lower is better)Bottom 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 29%
- 6-month returnTop 40%
- 1-year return vs S&P 500Top 23%
- Distance from 52-week highTop 22%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsBottom 49%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 45%
- Maximum drawdown, 3 yearsBottom 37%
- Beta vs S&P 500 (lower is better)Top 27%
- Net debt / EBITDA (lower is better)Bottom 21%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -1.9% | -0.2% | ↑ |
| EPS growth (YoY) | -61.4% | -67.0% | ↓ |
| Gross margin | 58.0% | 66.8% | ↑ |
| Operating margin | 19.8% | 10.5% | ↓ |
| FCF margin | 6.6% | 15.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -0.2% | -1.9% | ↑ | Bottom 29% |
| EPS growth (TTM, YoY) | -67.0% | -61.4% | ↓ | Bottom 23% |
| Gross margin | 66.8% | 58.0% | ↑ | Top 47% |
| Operating margin | 10.5% | 19.8% | ↓ | Top 26% |
| Net margin | 4.2% | 12.8% | ↓ | — |
| Free-cash-flow margin | 15.5% | 6.6% | ↑ | — |
| Return on invested capital | 8.7% | — | Top 17% | |
| Revenue growth, 3-year CAGR | -3.2% | — | Bottom 18% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -17.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 8.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +6.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.70×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.77%
- Net buyback yield (TTM)
- 4.11%
- Shareholder yield
- 6.88%
- Share count change, 1 year
- -2.9%
- Share count change, 3-year CAGR
- -3.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 1 of 2
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- -2.1%
- Positive 20 days after report
- 6 of 8
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 28, 2026 | +306.7% | +5.0% | -8.3% | +3.1% | — |
| Apr 28, 2026 | — | -1.6% | +6.5% | +11.3% | +21.7% |
| Feb 3, 2026 | — | -19.5% | -29.8% | -38.9% | -24.5% |
| Oct 27, 2025 | — | -2.1% | +14.6% | +51.5% | +88.8% |
| Jul 28, 2025 | — | +0.4% | -9.4% | +10.7% | -14.1% |
| Apr 28, 2025 | — | +1.1% | +19.1% | +26.8% | +37.4% |
| Feb 11, 2025 | — | +1.6% | +2.1% | -13.6% | -24.1% |
| Oct 25, 2024 | — | -1.9% | -0.9% | +6.3% | -1.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | $0.31 | -$0.15 | +306.7% | $35.4M |
| Apr 28, 2026 | $0.21 | — | — | $34.8M |
| Feb 3, 2026 | $0.16 | — | — | $35.2M |
| Oct 27, 2025 | $0.23 | — | — | $34.6M |
| Jul 28, 2025 | $0.28 | — | — | $34.0M |
| Apr 28, 2025 | $0.25 | — | — | $33.6M |
| Feb 11, 2025 | $0.36 | — | — | $36.9M |
| Oct 25, 2024 | $0.24 | — | — | $35.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 80.6× | 27.1× | 100th | Top 26% |
| P/E (forward) | 23.1× | — | — | — |
| EV / EBITDA | 23.3× | — | — | Top 26% |
| EV / Sales | 3.90× | — | — | Top 47% |
| Free-cash-flow yield | 4.72% | — | — | Top 19% |
| Earnings yield | 1.24% | — | — | Top 26% |
P/E over the past five years
Range 12.6× – 77.6× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +62.8%
- Earnings per share growth (TTM)
- -67.0%
- Change in P/E multiple
- +293.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 144
- 50-day average slope (20 days)
- -1.1%
- 200-day average slope (20 days)
- +2.3%
- Distance from 50-day average
- -3.1%
- Distance from 200-day average
- +7.3%
- RSI (14)
- 45.2
- Relative volume
- 0.92×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 58.3%
- Volatility vs own 5-year history
- 91th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.69
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- -10.6%
- Maximum drawdown, 3 years
- -78.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 11, 2020 | Apr 21, 2025 | -82.8% | 1113 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $458.6M
- P/E (TTM)
- 80.6
- EPS, diluted (TTM)
- $0.25
- Revenue (TTM)
- $140.0M
- Dividend yield
- 3.14%
- 52-week range
- $11.01 – $23.68
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Gross profit | $95.6M | $94.5M | $92.6M | $86.1M | $77.4M |
| Operating income | $50.3M | $46.5M | $40.0M | $35.2M | $22.6M |
| Net income | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| EPS (diluted) | $1.46 | $1.27 | $1.25 | $1.04 | $0.52 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.8M | $36.9M | $33.6M | $34.0M | $34.6M | $35.2M | $34.8M | $35.4M |
| Net income | $5.7M | $6.6M | $5.8M | -$106,000 | $4.1M | $1.8M | $3.2M | -$3.3M |
| EPS (diluted) | $0.24 | $0.28 | $0.25 | -$0.00 | $0.18 | $0.08 | $0.14 | -$0.15 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $46.3M | $36.3M | $38.1M | $34.6M | $26.4M |
| Capital expenditure | -$5.5M | -$9.8M | -$15.8M | -$15.4M | -$10.7M |
| Free cash flow | $40.8M | $26.4M | $22.3M | $19.2M | $15.7M |
| Dividends paid | -$9.2M | -$21.0M | -$36.4M | -$11.5M | -$11.0M |
| Net share buybacks | -$4.1M | -$27.6M | -$19.1M | -$30.9M | -$20.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $3.3M
- Total assets
- $136.2M
- Total liabilities
- $129.6M
- Total debt
- $90.0M
- Net debt
- $86.7M
- Shareholders’ equity
- $6.5M
As of Jun 30, 2026 (filed Aug 4, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 25, 2026 | $0.16 | Oct 9, 2026 |
| Jun 26, 2026 | $0.16 | Jul 10, 2026 |
| Mar 27, 2026 | $0.16 | Apr 10, 2026 |
| Dec 26, 2025 | $0.16 | Jan 9, 2026 |
| Sep 26, 2025 | $0.12 | Oct 10, 2025 |
| Jun 27, 2025 | $0.12 | Jul 11, 2025 |
| Mar 28, 2025 | $0.12 | Apr 11, 2025 |
| Dec 27, 2024 | $0.12 | Jan 10, 2025 |
Short interest
- Shares sold short
- 685,377
- Days to cover
- 5.93
- Change vs previous report
- +7.6%
FINRA short interest, settlement date Sep 15, 2026.